Free Trial

Polarean Imaging (POLX) Competitors

Polarean Imaging logo
GBX 1.02 -0.03 (-3.14%)
As of 07/25/2025 11:18 AM Eastern

POLX vs. CREO, IUG, NCYT, IHC, AVO, RUA, SUN, MHC, MXCT, and BELL

Should you be buying Polarean Imaging stock or one of its competitors? The main competitors of Polarean Imaging include Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), Novacyt (NCYT), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), RUA Life Sciences (RUA), Surgical Innovations Group (SUN), MyHealthChecked (MHC), MaxCyte (MXCT), and Belluscura (BELL). These companies are all part of the "medical devices" industry.

Polarean Imaging vs. Its Competitors

Polarean Imaging (LON:POLX) and Creo Medical Group (LON:CREO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability, media sentiment and institutional ownership.

12.1% of Polarean Imaging shares are owned by institutional investors. Comparatively, 56.1% of Creo Medical Group shares are owned by institutional investors. 39.3% of Polarean Imaging shares are owned by company insiders. Comparatively, 22.4% of Creo Medical Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Polarean Imaging has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Comparatively, Creo Medical Group has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500.

Creo Medical Group has higher revenue and earnings than Polarean Imaging. Creo Medical Group is trading at a lower price-to-earnings ratio than Polarean Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Polarean Imaging£5.21M2.87-£69.44M-£3.89-0.26
Creo Medical Group£33.87M1.64-£25.04M-£6.32-2.18

In the previous week, Creo Medical Group had 6 more articles in the media than Polarean Imaging. MarketBeat recorded 6 mentions for Creo Medical Group and 0 mentions for Polarean Imaging. Creo Medical Group's average media sentiment score of 0.26 beat Polarean Imaging's score of 0.00 indicating that Creo Medical Group is being referred to more favorably in the news media.

Company Overall Sentiment
Polarean Imaging Neutral
Creo Medical Group Neutral

Creo Medical Group has a net margin of -73.93% compared to Polarean Imaging's net margin of -1,333.97%. Creo Medical Group's return on equity of -41.79% beat Polarean Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Polarean Imaging-1,333.97% -86.11% -32.28%
Creo Medical Group -73.93%-41.79%-20.09%

Summary

Creo Medical Group beats Polarean Imaging on 9 of the 13 factors compared between the two stocks.

Get Polarean Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POLX vs. The Competition

MetricPolarean ImagingMedical Devices IndustryMedical SectorLON Exchange
Market Cap£14.93M£3.50B£5.74B£3.02B
Dividend YieldN/A2.44%4.71%5.02%
P/E Ratio-0.2675.9528.41160.65
Price / Sales2.87100.54419.59278,114.29
Price / Cash4.9315.9936.1827.97
Price / Book0.313.918.654.70
Net Income-£69.44M£132.05M£3.25B£5.90B
7 Day Performance-9.28%3.86%4.31%0.41%
1 Month Performance-25.87%16.66%11.60%7.20%
1 Year Performance-44.27%17.49%35.38%70.38%

Polarean Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POLX
Polarean Imaging
N/AGBX 1.02
-3.1%
N/A-43.7%£14.93M£5.21M-0.2628
CREO
Creo Medical Group
N/AGBX 13.79
-1.5%
N/A-55.6%£55.75M£33.87M-2.18279News Coverage
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57M-18.9165
NCYT
Novacyt
N/AGBX 41.64
+1.2%
N/A-14.5%£28.77M£18.12M-0.76120
IHC
Inspiration Healthcare Group
N/AGBX 22.40
-0.4%
N/A-15.5%£19.40M£42.87M-1.54224
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
RUA
RUA Life Sciences
N/AGBX 11.52
-2.0%
N/A+4.7%£7.15M£4.05M-2.6848
SUN
Surgical Innovations Group
N/AGBX 0.70
+0.3%
N/A-17.4%£6.55M£12.54M-21.1180
MHC
MyHealthChecked
N/AGBX 12.05
-3.6%
N/A+20.5%£6.27M£9.43M-6.0116Gap Up
MXCT
MaxCyte
N/AGBX 2.33
+4.0%
N/A-99.4%£3.08M£57.52M-0.0980High Trading Volume
BELL
Belluscura
N/AGBX 0.75
flat
N/AN/A£1.89M£2.87M-0.0824

Related Companies and Tools


This page (LON:POLX) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners